Therefore, investigating the expression pattern and the detailed role of TIM-3 in the metabolic alteration of tumor-infiltrating lymphocytes (TILs) as well as the tumor cells of HCC is of critical importance in finding more specific and effective therapeutic approaches in the future. The gene discussed is HAVCR2; the disease is hepatocellular carcinoma.